Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  • Communities & Collections
  • All of ANSTO Publications Online
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Moore, DE"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Studies on 99mtc-pertechnetate from the MEK solvent extraction generator
    (Australian Atomic Energy Commission, 1984-12) Mohammad, R; Moore, DE; Maddalena, DJ; Boyd, RE
    Analysis by gas chromatography-mass spectrometry and high performance liquid chromatography has revealed organic residues in (99m)Tc-pertechnetate obtained from 99Mo-molybdate by extraction using the organic solvent methylethylketone (MEK). The organic residues have been identified as either (i) low molecular weight carbonyl compounds such as formaldehyde acetaldehyde and acetone presumably caused by the effects of gamma-radiation on MEK or (ii) condensation products resulting from the action of strong alkali on MEK during the extraction process. The quantities of organic residues varied from batch to batch of extracted pertechnetate; up to 40 μg mL -1 was found. When these compounds were tested in rats by addition to a pyrophosphate bone-seeking radiopharmaceutical the tissue distribution was not significantly different from that in the control which contained no added compound. Assay for 99Tc in MEK-derived pertechnetate indicated up to 10 μg mL -1 of 99Tc carrier. An assessment of the biological effect of 99Tc carrier was obtained by (i) red blood cell labelling where 6 ng mL -1 of 99Tc was sufficient to reduce labelling efficiency; and (ii) pyrophosphate tissue distribution where a significant effect was obtained in the presence of 10 μg mL -1 of 99Tc carrier.

ANSTO Publications Online software copyright © 2002-2025 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback